Zai Lab outlines $460M+ 2025 revenue guidance amid global pipeline acceleration and commercial growth
Source: SeekingAlpha
2025-11-07 08:17:00 ET
More on Zai Lab
- Zai Lab Limited (ZLAB) Q3 2025 Earnings Call Transcript
- Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Zoci and Outlines Next Steps in Clinical Development Transcript
- Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Zoci and Outlines Next Steps in Clinical Development - Slideshow
- Zai Lab Non-GAAP EPS of -$0.33 misses by $0.04, revenue of $116.09M misses by $27.64M
- Zai Lab Q3 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Zai Lab outlines $460M+ 2025 revenue guidance amid global pipeline acceleration and commercial growth
Zai Lab Limited
NASDAQ: ZLAB
ZLAB Trading
-1.63% G/L:
$18.365 Last:
202,921 Volume:
$18.85 Open:
ZLAB Latest News
February 26, 2026 07:00:00 am
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
ZLAB Stock Data
$2,174,273,322
105,108,310
0.9%
39
N/A
Biotechnology & Life Sciences
Healthcare
CN
Shanghai
